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Gastric neuroendocrine carcinomas are rare and have a poor prognosis, and the diagnostic criteria for this disease have
recently changed. We herein report a case of sporadic gastric neuroendocrine carcinoma. A 75-year-old man was referred to
our hospital with epigastric pain. Endoscopic examination revealed a localized ulcerative lesion (diameter, 4cm) at the upper
stomach.Thediagnosisonbiopsywasneuroendocrinecarcinoma.TotalgastrectomywithD2lymphadenectomy,splenectomy,and
cholecystectomy was performed. Pathologically, the tumor inﬁltrated the subserosal layer, and 6/49 lymph nodes were involved.
Thetumorwasuniforminshapeandarrangedinarosette-likestructuretoformsolidnests,withmedium-sized,round-to-cuboid-
shaped tumor cells and intense mitosis 46/10 HPF. It was positive for synaptophysin and chromogranin A, and the Ki-67 labeling
index was 70–80%. The diagnosis of neuroendocrine carcinoma was made according to the WHO 2010 criteria. The patient was
followed up for three years without recurrence.
1.Introduction
Neuroendocrine carcinomas (NECs) of the stomach, al-
though rare, deserve particular attention as they are ag-
gressive and have an extremely poor prognosis [1–6]. In ad-
dition, the concept of this disease and its diagnostic criteria
have been changed recently. The World Health Organization
(WHO) proposed new diagnostic criteria in 2010 that
mainly depend on the rate of cellular proliferation [7].
In this paper, we describe a case of sporadic gastric NEC
with a ﬁne outcome. We also describe novel suggestions for
the diagnosis of gastric NEC.
2. Case Presentation
A 75-year-old man was referred to our hospital with left
epigastric pain. Upper endoscopic examination revealed a
localized ulcerative lesion (diameter, 4cm) located on the
lesser curvature of the upper stomach (Figure 1). The tumor
was thought to invade the subserosal layer. A biopsy of
the lesion gave the diagnosis of NEC. Patient interview
revealed no particular past history or familial history.
No extragastric hormonal syndromes, such as ﬂushes or
diarrhea, were identiﬁed. After obtaining informed consent,
at o t a lga s tr e ct o m ywi t hD 2l ym p h a d e n e ct o m y ,s p l e n e ct o m y ,
and cholecystectomy was performed [8]. Pathologically, the
tumor was 30 × 27mm in size and with a negative margin.
The tumor inﬁltrated the subserosal layer. Microscopically,
the tumor was uniform in shape and arranged in small
microtubular structures (rosette-like arrangement) to form
solid nests, with medium-sized, round-to-cuboid-shaped
tumor cells containing clear and rich cytoplasm. The tumor
cells exhibited hyperchromatic nuclei and intense mitosis
46/10 HPF (Figure 2(a)). Lymphatic invasion was widely
observed and lymph node involvement was seen in 6/49
nodes. By immunohistochemical staining, the tumor cells
werepositiveforsynaptophysin(Figure 2(b)),chromogranin
A( Figure 2(c)), and CEA and negative for S-100 protein.
The Ki-67 labeling index was 70–80% (Figure 2(d)). These
ﬁndings led to the diagnosis of NEC of the large cell type2 Case Reports in Medicine
Figure 1: Upper endoscopic examination revealed a localized
ulcerative lesion (diameter, 4cm) located on the lesser curvature of
the upper stomach.
according to the 2010 WHO criteria [7]. The postoperative
course was uneventful, and the patient was followed up
withoutanymaintenancetherapyforthreeyearswithoutany
ﬁndings indicative of recurrence or distant metastasis.
3. Discussion
Gastric neuroendocrine neoplasms (NENs) embrace a group
of tumors that exhibit a spectrum of histopathologic var-
iations, ranging from clearly benign tumors to highly ma-
lignant ones. Recently, the concept of this disease and its
diagnostic criteria have been changed. In the 2010 WHO
criteria, NENs of the stomach are deﬁned as neoplasms with
neuroendocrine diﬀerentiation, including neuroendocrine
tumors (NETs) and NECs arising in the stomach [7]. Syn-
onyms for gastric NETs include carcinoid, well-diﬀerentiated
endocrinetumor/carcinomas,andenterochromaﬃn-likecell
NETs, and synonyms for NECs include poorly diﬀerentiated
endocrine carcinomas and small cell and large cell endocrine
carcinomas.NENsareclassiﬁedintoNETG1(carcinoid)and
G2, NECs, mixed adenoneuroendocrine carcinomas, ente-
rochromaﬃn cells, serotonin-producing NETs, and gastrin-
producing NETs [7]. In the Japanese Classiﬁcation of Gastric
Carcinoma, NENs are classiﬁed into carcinoid tumors and
endocrinecarcinomas(smallcelltypeandlargecelltype)[8].
Although the prevalence of gastric NENs has recently
risen, they are thought to be relatively rare tumors that
account for less than 1% of all gastric tumors [9]. In general,
the majority of these tumors are NETs, whose courses are
indolent and not life threatening. Concerning NETs, more
than 100 years have passed since Oberndorfer proposed
the term “carcinoid” in 1907 [10]. In 1993, Rindi et al.
advocated a classiﬁcation system with three subtypes of
gastric carcinoid tumors according to the clinicopathological
features [1], and this classiﬁcation system is reﬂected in
the 2010 WHO criteria. On this background, Gilligan et
al. advocated a treatment algorithm for gastric carcinoid
tumors, including the above-mentioned subtypes as well as
the size and number of tumors [11]. Recently, less invasive
therapeutic options, such as endoscopic resection of the
tumor, have been reported for small NETs [12].
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Figure 2:Histologicalﬁndingsofthetumor(x400).Thetumorwas
uniform in shape and arranged in small microtubular structures
(rosette-like arrangement) to form solid nests, with medium-sized,
round-to-cuboid-shaped tumor cells. The tumor cells exhibited
intense mitosis greater than 2/HPF (hematoxylin and eosin, (a)).
Immunohistochemical staining showed that it was positive for
synaptophysin (b) and chromogranin A (c). The Ki-67 labeling
index was 70–80% (d).Case Reports in Medicine 3
NECs of the stomach are also rare, representing less than
10% of gastric NENs [2, 13], and such rarity has made
it diﬃcult to understand precisely their biological nature
and to establish optimal treatment options. The NEC of
our case was a diﬃcult diagnosis to establish, and the im-
munohistochemistry played a major role. Microscopically,
the patient’s tumor was uniform in shape and arranged
in small microtubular structures (rosette-like arrangement)
to form solid nests, with medium-sized, round-to-cuboid-
shaped tumor cells on hematoxylin and eosin staining. On
immunohistochemistry, the tumors are usually positive for
synaptophysin and neuronal-speciﬁc enolase, but are rarely
positive for the chromogranin A staining observed in our
patient. In the 2010 WHO criteria, NENs are classiﬁed into
NETs or NECs on the basis of the level of cellular prolifer-
ation, including the mitotic and Ki-67 indices. The mitotic
index was 46/10HPF and the Ki-67 labeling index was 70–
80% in our case, so he was diagnosed as NEC. Lymphatic
invasion was widely observed and lymph node involvement
was seen in many nodes, suggesting the high-grade malig-
nant nature of this tumor and showing the compatibility of
the diagnosis. Aggressive surgery and chemotherapy should
be considered for any NEC [3] .At o t a lg a s t r e c t o m yw i t hD 2
lymphadenectomy, splenectomy, and cholecystectomy was
performed on our patient, and he has lived disease-free for
three years without any maintenance therapy.
In conclusion, we described a case of sporadic gastric
NEC. An adequate description of NECs should be globally
andhistoricallydiscussedinrelationtotherealmanifestation
of this tumor group, considering the evaluation of the
Consensus Conference. The diagnosis and treatment of these
tumors should be evaluated in large clinical studies.
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